Raimundo Bezares

649 total citations
29 papers, 400 citations indexed

About

Raimundo Bezares is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Raimundo Bezares has authored 29 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 14 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Raimundo Bezares's work include Chronic Lymphocytic Leukemia Research (26 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Raimundo Bezares is often cited by papers focused on Chronic Lymphocytic Leukemia Research (26 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Raimundo Bezares collaborates with scholars based in Argentina, Uruguay and Venezuela. Raimundo Bezares's co-authors include Mirta Giordano, Romina Gamberale, Mercedes Borge, Irma Slavutsky, Ana Colado, Enrique Podaza, Pablo Elías Morande, María Belén Almejún, Pablo Oppezzo and Analía Trevani and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer.

In The Last Decade

Raimundo Bezares

29 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raimundo Bezares Argentina 14 212 185 116 115 81 29 400
Jenny Bulgarelli Italy 10 178 0.8× 167 0.9× 153 1.3× 78 0.7× 98 1.2× 20 389
Mercedes Borge Argentina 13 166 0.8× 190 1.0× 85 0.7× 74 0.6× 57 0.7× 22 330
Steve Pavletic United States 5 146 0.7× 133 0.7× 127 1.1× 80 0.7× 73 0.9× 5 386
Gianluca Schiavoni Italy 10 276 1.3× 128 0.7× 184 1.6× 177 1.5× 114 1.4× 17 440
Alexandra Schrader Germany 9 142 0.7× 150 0.8× 103 0.9× 203 1.8× 189 2.3× 20 402
JK Larsen Denmark 12 254 1.2× 196 1.1× 86 0.7× 227 2.0× 102 1.3× 17 448
Kamlai Saiya-Cork United States 11 201 0.9× 131 0.7× 191 1.6× 222 1.9× 124 1.5× 15 480
Adéla Berková Czechia 11 140 0.7× 75 0.4× 172 1.5× 127 1.1× 76 0.9× 26 391
Akif Selim Yavuz Türkiye 10 159 0.8× 458 2.5× 119 1.0× 77 0.7× 35 0.4× 34 647
Gustav Klobeck Germany 8 91 0.4× 120 0.6× 221 1.9× 154 1.3× 154 1.9× 9 472

Countries citing papers authored by Raimundo Bezares

Since Specialization
Citations

This map shows the geographic impact of Raimundo Bezares's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raimundo Bezares with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raimundo Bezares more than expected).

Fields of papers citing papers by Raimundo Bezares

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raimundo Bezares. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raimundo Bezares. The network helps show where Raimundo Bezares may publish in the future.

Co-authorship network of co-authors of Raimundo Bezares

This figure shows the co-authorship network connecting the top 25 collaborators of Raimundo Bezares. A scholar is included among the top collaborators of Raimundo Bezares based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raimundo Bezares. Raimundo Bezares is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Colado, Ana, Miguel Arturo Pavlovsky, Raimundo Bezares, et al.. (2023). Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia. Frontiers in Oncology. 13. 1143881–1143881. 5 indexed citations
3.
Bezares, Raimundo, et al.. (2021). Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients. Annals of Hematology. 101(2). 341–348. 2 indexed citations
4.
Colado, Ana, Ernesto Gargiulo, Raimundo Bezares, et al.. (2021). In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia. Frontiers in Oncology. 11. 598319–598319. 17 indexed citations
5.
Colado, Ana, Enrique Podaza, María Belén Almejún, et al.. (2020). Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia. Cancer Immunology Immunotherapy. 69(5). 813–824. 6 indexed citations
6.
Podaza, Enrique, Ana Colado, María Belén Almejún, et al.. (2018). Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16highCD62Ldim immunosuppressive subset. International Journal of Cancer. 144(5). 1128–1134. 19 indexed citations
7.
Podaza, Enrique, María Belén Almejún, Ana Colado, et al.. (2017). Revisiting the role of interleukin-8 in chronic lymphocytic leukemia. Scientific Reports. 7(1). 15714–15714. 14 indexed citations
8.
Bezares, Raimundo, et al.. (2017). Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia. PLoS ONE. 12(6). e0179883–e0179883. 12 indexed citations
9.
Colado, Ana, María Belén Almejún, Enrique Podaza, et al.. (2016). The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients. Cancer Immunology Immunotherapy. 66(4). 461–473. 14 indexed citations
10.
Podaza, Enrique, Florencia Sabbione, Mercedes Borge, et al.. (2016). Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs). Cancer Immunology Immunotherapy. 66(1). 77–89. 58 indexed citations
11.
Bezares, Raimundo, et al.. (2015). Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia. Tumor Biology. 36(11). 8317–8324. 19 indexed citations
12.
Roisman, Alejandro, et al.. (2015). SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers. Tumor Biology. 36(6). 4433–4440. 13 indexed citations
13.
Morande, Pablo Elías, Mercedes Borge, Cecilia Abreu, et al.. (2014). Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia. Leukemia & lymphoma. 56(4). 1115–1122. 5 indexed citations
14.
Bezares, Raimundo, et al.. (2013). Immunoglobulin Gene Rearrangements and Mutational Status in Argentinian Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 13(4). 447–457.e2. 13 indexed citations
15.
Borge, Mercedes, Pablo Elías Morande, Carolina Jancic, et al.. (2012). CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients. Cancer Immunology Immunotherapy. 62(1). 113–124. 17 indexed citations
16.
Morande, Pablo Elías, Samanta Romina Zanetti, Mercedes Borge, et al.. (2011). The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells. Investigational New Drugs. 30(5). 1830–1840. 18 indexed citations
17.
18.
19.
Galletti, Jeremías G., Pablo Elías Morande, Mercedes Borge, et al.. (2008). Chronic Lymphocytic Leukemia Cells Bind and Present the Erythrocyte Protein Band 3: Possible Role as Initiators of Autoimmune Hemolytic Anemia. The Journal of Immunology. 181(5). 3674–3683. 24 indexed citations
20.
Schillaci, Roxana, et al.. (2005). Autocrine/paracrine involvement of insulin‐like growth factor‐I and its receptor in chronic lymphocytic leukaemia. British Journal of Haematology. 130(1). 58–66. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenny Bulgarelli Breakdown of academic impact, for papers by Mercedes Borge Breakdown of academic impact, for papers by Steve Pavletic Breakdown of academic impact, for papers by Gianluca Schiavoni Breakdown of academic impact, for papers by Alexandra Schrader Breakdown of academic impact, for papers by JK Larsen Breakdown of academic impact, for papers by Kamlai Saiya-Cork Breakdown of academic impact, for papers by Adéla Berková Breakdown of academic impact, for papers by Akif Selim Yavuz Breakdown of academic impact, for papers by Gustav Klobeck
Rankless by CCL
2026